Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria-Reference-Cited by-同舟云学术

Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria

Published:2014-01-13 Issue:4 Volume:15 Page:453-459
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Fogari Roberto,Derosa Giuseppe,Zoppi Annalisa,Lazzari Pierangelo,D'Angelo Angela,Mugellini Amedeo

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2014.874415

Reference41 articles.

1. Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention

2. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

3. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

4. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA);Clinical Kidney Journal;2023-06-24

2. Role of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease;Kidney and Dialysis;2022-04-08

3. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease;Cochrane Database of Systematic Reviews;2020-10-27

4. Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials;Journal of General Internal Medicine;2020-03-10

5. Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease;Journal of Hypertension;2019-12